Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renuka Surujnarain

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Psychiatric Services (Washington, D.C.)|May 20, 2026
When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical ResponsibilitiesJoshua Mitchell, Benjamin Bregman, Renuka Surujnarain, et al.
Journal of Affective Disorders|July 7, 2025
Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabisDavid Wolinsky, Rhiannon E Mayhugh, Renuka Surujnarain, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Psychiatric Services (Washington, D.C.)|May 20, 2026
When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical ResponsibilitiesJoshua Mitchell, Benjamin Bregman, Renuka Surujnarain, et al.
Journal of Affective Disorders|July 7, 2025
Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabisDavid Wolinsky, Rhiannon E Mayhugh, Renuka Surujnarain, et al.
Pageof 1